Related Experiment Video
Updated: Jul 10, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
The many ways to frontotemporal degeneration and beyond
1IRCCS Carlo Besta, Via Celoria 11, I-20133, Milan, Italy. bugiani1@virgilio.it
Summary
Frontotemporal degeneration (FTD) is a common dementia. Recent research reveals diverse FTD phenotypes and molecular classifications, identifying key genetic and protein factors contributing to neurodegeneration.
Area of Science:
- Neurology
- Neuroscience
- Genetics
Background:
- Frontotemporal degeneration (FTD) is the second most common dementia after Alzheimer's disease.
- FTD research is ongoing and intensive.
Purpose of the Study:
- To summarize recent findings in the biology of frontotemporal degeneration.
- To provide an overview of FTD phenotypes, molecular classifications, and genetic underpinnings.
Main Methods:
- Literature review of frontotemporal degeneration research.
Main Results:
- FTD exhibits diverse phenotypes, including behavioral changes, progressive aphasia, semantic dementia, and motor neuron disease.
- Molecular classification separates FTD based on tau, ubiquitin, or other inclusions.
- Seven genetic loci and four genes (MAPT, PRGN, VCP, CHMP2B) are implicated in FTD.
- Key proteins involved include tau, progranulin, VCP, CHMP2B, TDP43, and ubiquitin.
Conclusions:
- Neurodegeneration in FTD likely results from disruptions in cytoskeletal structure and ubiquitin-dependent protein degradation.
- Understanding FTD's complex biology is crucial for developing effective treatments.
More Related Videos
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...